← Back
Data updated: Mar 10, 2026
TAIHO ONCOLOGY
OncologyGastroenterology
TAIHO ONCOLOGY is a pharmaceutical company focused on Oncology, Gastroenterology. Key products include INQOVI.
2015
Since
3
Drugs
-
Trials
2
Approved (2yr)
Key Drugs
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 85%
2 drugs Phase 3: 4 Phase 2: 10 Phase 1: 19
Gastroenterology 15%
1 drugs Phase 3: 1 Phase 2: 1
Pipeline Strength Pro
Loading...